Pregnancy vaccine reduces baby hospital admissions for RSV by 80%

BBC reports that a UK Health Security Agency study of nearly 300,000 births shows a maternal RSV vaccine administered during pregnancy reduces hospital admissions for babies by over 80%, with strongest protection when given at least four weeks before delivery. The reporting is grounded in official UKHSA statements, specific data (85% protection rate, 4,500+ hospitalizations analyzed, 64% vaccination uptake in England), and named sources including Dr. Conall Watson. Independent corroboration from PRNewswire, GOV.UK, and Nature's Journal of Perinatology confirms both the study's scale and findings, while Prism News reports similar protection figures (81.3%), validating the headline claim. The article appropriately contextualizes RSV as a leading cause of infant hospitalization (20,000+ cases annually in the UK) and includes a patient testimony (Malachi's case) that underscores severity while acknowledging rare adverse outcomes, balancing emotional resonance with factual reporting. Watch for uptake trends in London (53% vs. 64% nationally) and any policy efforts to improve vaccination rates among pregnant women, particularly in underserving regions.